MOLLER CHRISTOPHER

Officer at Traffic.com, Inc. · on record since Jan 24, 2006
10% owner at IMMUNICON CORP · on record since Apr 14, 2004
Co-investr, TL Ventures III LP at Traffic.com, Inc. · on record since Mar 8, 2007
10% owner at BARRIER THERAPEUTICS INC · on record since Apr 28, 2004
Director at EPIRUS Biopharmaceuticals, Inc. · on record since Nov 9, 2005

Insider trading activity of MOLLER CHRISTOPHER

Transactions on record: 12; since Nov 16, 2005

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Nov 16, 2005

Figures computed from official regulatory filings — .

Companies where MOLLER CHRISTOPHER has traded

EPIRUS Biopharmaceuticals, Inc.12 tx · Nov 16, 2005

Track record of MOLLER CHRISTOPHER

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of MOLLER CHRISTOPHER

Co-insiders of MOLLER CHRISTOPHER

DENINO MARK JBARRIER THERAPEUTICS INC +3
KEITH ROBERT E JRBARRIER THERAPEUTICS INC +3
DAVIS CHRISTOPHER JBARRIER THERAPEUTICS INC +1
ERICKSON EDWARD LBARRIER THERAPEUTICS INC +1
EVNIN LUKEBARRIER THERAPEUTICS INC +1
GADICKE ANSBERTBARRIER THERAPEUTICS INC +1
GALAKATOS NICHOLASBARRIER THERAPEUTICS INC +1
HENNER DENNISBARRIER THERAPEUTICS INC +1
JOHNSON & JOHNSONBARRIER THERAPEUTICS INC +1
JOHNSON & JOHNSON DEVELOPMENT CORP ET ALBARRIER THERAPEUTICS INC +1
MPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLCBARRIER THERAPEUTICS INC +1
MPM BIOVENTURES III GMBH & CO. Beteiligungs KGBARRIER THERAPEUTICS INC +1
MPM BIOVENTURES III GP LPBARRIER THERAPEUTICS INC +1
MPM BIOVENTURES III LLCBARRIER THERAPEUTICS INC +1
MPM BIOVENTURES III LPBARRIER THERAPEUTICS INC +1
MPM BIOVENTURES III PARALLEL FUND, LPBARRIER THERAPEUTICS INC +1
MPM BIOVENTURES III QP LPBARRIER THERAPEUTICS INC +1
OSTRO MARC JBARRIER THERAPEUTICS INC +1
RUDNICK SETHEPIRUS Biopharmaceuticals, Inc. +1

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	OtherD (derivative)	-22,669	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	OtherD (derivative)	-1,310,664	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	Other	748,951	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	Other	834,224	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	OtherD (derivative)	-4,409	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	OtherD (derivative)	-1,311,300	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	OtherD (derivative)	-254,940	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	Other	12,954	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	Other	2,519	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	OtherD (derivative)	-22,650	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	Other	14,409	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	Other	145,680	—	n/a (No price was disclosed in the filing)	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	OtherD (derivative)	-22,669	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	OtherD (derivative)	-1,310,664	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	Other	748,951	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	Other	834,224	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	OtherD (derivative)	-4,409	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	OtherD (derivative)	-1,311,300	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	OtherD (derivative)	-254,940	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	Other	12,954	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	Other	2,519	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	OtherD (derivative)	-22,650	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	Other	14,409	—	n/a (No price was disclosed in the filing)	SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Nov 16, 2005	Other	145,680	—	n/a (No price was disclosed in the filing)	SEC